Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma

20 maart 2020 bijgewerkt door: Southwest Oncology Group

A Phase II Trial of the Combination of OSI-774 (ERLOTINIB; NSC-718781) and Bevacizumab (Rhumab VEGF; NSC-704865) in Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features (ADENOBAC)

RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor. Giving erlotinib together with bevacizumab may kill more tumor cells.

PURPOSE: This phase II trial is studying how well giving erlotinib together with bevacizumab works in treating patients with stage III or stage IV non-small cell lung cancer.

Studie Overzicht

Toestand

Voltooid

Conditie

Interventie / Behandeling

Gedetailleerde beschrijving

OBJECTIVES:

Primary

  • Determine overall survival of patients with stage IIIB or IV bronchioloalveolar carcinoma (BAC) or adenocarcinoma with BAC features treated with erlotinib hydrochloride and bevacizumab.

Secondary

  • Determine the progression-free survival of patients treated with this regimen.
  • Compare, preliminarily, response as assessed by RECIST criteria vs response as assessed by a central computer-assisted image-analysis system in patients with measurable disease treated with this regimen.
  • Assess the frequency and severity of toxicities of this regimen in these patients.

OUTLINE: This is a multicenter study.

Patients receive oral erlotinib hydrochloride once daily on days 1-21 and bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed every 3 months for 1 year and then every 6 months for up to 2 years.

PROJECTED ACCRUAL: A total of 80 patients will be accrued for this study.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

84

Fase

  • Fase 2

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

  • Verenigde Staten
    • California
      • Antioch, California, Verenigde Staten, 94531
        • Kaiser Permanente - Deer Valley
      • Berkeley, California, Verenigde Staten, 94704
        • Alta Bates Summit Comprehensive Cancer Center
      • Burlingame, California, Verenigde Staten, 94010
        • Peninsula Medical Center
      • Fremont, California, Verenigde Staten, 94538
        • Kaiser Permanente - Fremont
      • Hayward, California, Verenigde Staten, 94545
        • Kaiser Permanente Medical Center - Hayward
      • Marysville, California, Verenigde Staten, 95901
        • Tibotec Therapeutics - Division of Ortho Biotech Products, LP
      • Oakland, California, Verenigde Staten, 94611
        • Kaiser Permanente Medical Center - Oakland
      • Pleasanton, California, Verenigde Staten, 94588
        • Valley Medical Oncology Consultants - Pleasanton
      • Redwood City, California, Verenigde Staten, 94063
        • Kaiser Permanente Medical Center - Redwood City
      • Richmond, California, Verenigde Staten, 94801
        • Kaiser Permanente Medical Center - Richmond
      • Roseville, California, Verenigde Staten, 95661
        • Kaiser Permanente Medical Center - Roseville
      • Sacramento, California, Verenigde Staten, 95817
        • University of California Davis Cancer Center
      • Sacramento, California, Verenigde Staten, 95823
        • South Sacramento Kaiser-Permanente Medical Center
      • Sacramento, California, Verenigde Staten, 95825
        • Kaiser Permanente Medical Center - Sacramento
      • San Francisco, California, Verenigde Staten, 94115
        • Kaiser Permanente Medical Center - San Francisco Geary Campus
      • San Francisco, California, Verenigde Staten, 94118
        • California Pacific Medical Center - California Campus
      • San Jose, California, Verenigde Staten, 95119
        • Kaiser Permanente Medical Center - Santa Teresa
      • San Rafael, California, Verenigde Staten, 94903
        • Sutter Health - Western Division Cancer Research Group
      • San Rafael, California, Verenigde Staten, 94903
        • Kaiser Foundation Hospital - San Rafael
      • Santa Clara, California, Verenigde Staten, 95051
        • Kaiser Permanente Medical Center - Santa Clara Kiely Campus
      • Santa Rosa, California, Verenigde Staten, 95403
        • Kaiser Permanente Medical Center - Santa Rosa
      • South San Francisco, California, Verenigde Staten, 94080
        • Kaiser Permanente Medical Center - South San Francisco
      • Stockton, California, Verenigde Staten, 95210
        • Kaiser Permanente Medical Facility - Stockton
      • Truckee, California, Verenigde Staten, 96161
        • Tahoe Forest Cancer Center
      • Vacaville, California, Verenigde Staten, 95688
        • Kaiser Permanente Medical Center - Vacaville
      • Vallejo, California, Verenigde Staten, 94589
        • Sutter Solano Medical Center
      • Vallejo, California, Verenigde Staten, 94589
        • Kaiser Permanente Medical Center - Vallejo
      • Walnut Creek, California, Verenigde Staten, 94596
        • Kaiser Permanente Medical Center - Walnut Creek
    • Connecticut
      • Hartford, Connecticut, Verenigde Staten, 06105
        • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    • Georgia
      • Atlanta, Georgia, Verenigde Staten, 30309
        • Piedmont Hospital
      • Atlanta, Georgia, Verenigde Staten, 30342-1611
        • Northside Hospital Cancer Center
      • Atlanta, Georgia, Verenigde Staten, 30342-1701
        • Saint Joseph's Hospital of Atlanta
      • Atlanta, Georgia, Verenigde Staten, 30342
        • CCOP - Atlanta Regional
      • Austell, Georgia, Verenigde Staten, 30106
        • WellStar Cobb Hospital
      • Columbus, Georgia, Verenigde Staten, 31904
        • John B. Amos Cancer Center
      • Decatur, Georgia, Verenigde Staten, 30033
        • Charles B. Eberhart Cancer Center at DeKalb Medical Center
      • Fayetteville, Georgia, Verenigde Staten, 30214
        • Piedmont Fayette Hospital
      • Gainesville, Georgia, Verenigde Staten, 30501
        • Northeast Georgia Medical Center
      • Lawrenceville, Georgia, Verenigde Staten, 30045
        • Gwinnett Medical Center
      • Marietta, Georgia, Verenigde Staten, 30060
        • Kennestone Cancer Center at Wellstar Kennestone Hospital
      • Riverdale, Georgia, Verenigde Staten, 30274-2600
        • Southern Regional Medical Center
      • Rome, Georgia, Verenigde Staten, 30165
        • Harbin Clinic Cancer Center - Medical Oncology
    • Hawaii
      • Honolulu, Hawaii, Verenigde Staten, 96819
        • Kaiser Permanente - Moanalua Medical Center and Clinic
    • Illinois
      • Decatur, Illinois, Verenigde Staten, 62526
        • Decatur Memorial Hospital Cancer Care Institute
      • Maywood, Illinois, Verenigde Staten, 60153
        • Cardinal Bernardin Cancer Center at Loyola University Medical Center
      • Springfield, Illinois, Verenigde Staten, 62781-0001
        • Regional Cancer Center at Memorial Medical Center
    • Kansas
      • Chanute, Kansas, Verenigde Staten, 66720
        • Cancer Center of Kansas, PA - Chanute
      • Dodge City, Kansas, Verenigde Staten, 67801
        • Cancer Center of Kansas, PA - Dodge City
      • El Dorado, Kansas, Verenigde Staten, 67042
        • Cancer Center of Kansas, PA - El Dorado
      • Fort Scott, Kansas, Verenigde Staten, 66701
        • Cancer Center of Kansas - Fort Scott
      • Independence, Kansas, Verenigde Staten, 67301
        • Cancer Center of Kansas-Independence
      • Kingman, Kansas, Verenigde Staten, 67068
        • Cancer Center of Kansas, PA - Kingman
      • Lawrence, Kansas, Verenigde Staten, 66044
        • Lawrence Memorial Hospital
      • Liberal, Kansas, Verenigde Staten, 67901
        • Cancer Center of Kansas, PA - Liberal
      • Newton, Kansas, Verenigde Staten, 67114
        • Cancer Center of Kansas, PA - Newton
      • Parsons, Kansas, Verenigde Staten, 67357
        • Cancer Center of Kansas, PA - Parsons
      • Pratt, Kansas, Verenigde Staten, 67124
        • Cancer Center of Kansas, PA - Pratt
      • Salina, Kansas, Verenigde Staten, 67401
        • Cancer Center of Kansas, PA - Salina
      • Salina, Kansas, Verenigde Staten, 67401
        • Tammy Walker Cancer Center at Salina Regional Health Center
      • Topeka, Kansas, Verenigde Staten, 66606
        • Cotton-O'Neil Cancer Center
      • Wellington, Kansas, Verenigde Staten, 67152
        • Cancer Center of Kansas, PA - Wellington
      • Wichita, Kansas, Verenigde Staten, 67208
        • Cancer Center of Kansas, PA - Medical Arts Tower
      • Wichita, Kansas, Verenigde Staten, 67214
        • Cancer Center of Kansas, PA - Wichita
      • Wichita, Kansas, Verenigde Staten, 67214
        • CCOP - Wichita
      • Wichita, Kansas, Verenigde Staten, 67214
        • Via Christi Cancer Center at Via Christi Regional Medical Center
      • Wichita, Kansas, Verenigde Staten, 67208
        • Associates in Womens Health, PA - North Review
      • Winfield, Kansas, Verenigde Staten, 67156
        • Cancer Center of Kansas, PA - Winfield
    • Kentucky
      • Lexington, Kentucky, Verenigde Staten, 40536-0093
        • Lucille P. Markey Cancer Center at University of Kentucky
    • Michigan
      • Ann Arbor, Michigan, Verenigde Staten, 48106-0995
        • Saint Joseph Mercy Cancer Center
      • Ann Arbor, Michigan, Verenigde Staten, 48106
        • CCOP - Michigan Cancer Research Consortium
      • Battle Creek, Michigan, Verenigde Staten, 49017
        • Battle Creek Health System Cancer Care Center
      • Big Rapids, Michigan, Verenigde Staten, 49307
        • Mecosta County Medical Center
      • Dearborn, Michigan, Verenigde Staten, 48123-2500
        • Oakwood Cancer Center at Oakwood Hospital and Medical Center
      • Flint, Michigan, Verenigde Staten, 48503
        • Hurley Medical Center
      • Flint, Michigan, Verenigde Staten, 48503
        • Genesys Hurley Cancer Institute
      • Grand Blanc, Michigan, Verenigde Staten, 48439
        • Genesys Regional Medical Center
      • Grand Rapids, Michigan, Verenigde Staten, 49503
        • Butterworth Hospital at Spectrum Health
      • Grand Rapids, Michigan, Verenigde Staten, 49503
        • CCOP - Grand Rapids
      • Grand Rapids, Michigan, Verenigde Staten, 49503
        • Lacks Cancer Center at Saint Mary's Health Care
      • Grosse Pointe Woods, Michigan, Verenigde Staten, 48236
        • Van Elslander Cancer Center at St. John Hospital and Medical Center
      • Jackson, Michigan, Verenigde Staten, 49201
        • Foote Memorial Hospital
      • Lansing, Michigan, Verenigde Staten, 48912-1811
        • Sparrow Regional Cancer Center
      • Livonia, Michigan, Verenigde Staten, 48154
        • St. Mary Mercy Hospital
      • Muskegon, Michigan, Verenigde Staten, 49443
        • Mercy General Health Partners
      • Pontiac, Michigan, Verenigde Staten, 48341-2985
        • St. Joseph Mercy Oakland
      • Port Huron, Michigan, Verenigde Staten, 48060
        • Mercy Regional Cancer Center at Mercy Hospital
      • Saginaw, Michigan, Verenigde Staten, 48601
        • Seton Cancer Institute at Saint Mary's - Saginaw
      • Traverse City, Michigan, Verenigde Staten, 49684
        • Munson Medical Center
      • Warren, Michigan, Verenigde Staten, 48093
        • St. John Macomb Hospital
      • Wyoming, Michigan, Verenigde Staten, 49519
        • Metro Health Hospital
    • Montana
      • Billings, Montana, Verenigde Staten, 59101
        • CCOP - Montana Cancer Consortium
      • Billings, Montana, Verenigde Staten, 59101
        • St. Vincent Healthcare Cancer Care Services
      • Billings, Montana, Verenigde Staten, 59107-7000
        • Billings Clinic - Downtown
      • Billings, Montana, Verenigde Staten, 59102
        • Hematology-Oncology Centers of the Northern Rockies - Billings
      • Bozeman, Montana, Verenigde Staten, 59715
        • Bozeman Deaconess Cancer Center
      • Butte, Montana, Verenigde Staten, 59701
        • St. James Healthcare Cancer Care
      • Great Falls, Montana, Verenigde Staten, 59405
        • Great Falls Clinic - Main Facility
      • Great Falls, Montana, Verenigde Staten, 59405-5309
        • Big Sky Oncology
      • Great Falls, Montana, Verenigde Staten, 59405
        • Sletten Cancer Institute at Benefis Healthcare
      • Havre, Montana, Verenigde Staten, 59501
        • Northern Montana Hospital
      • Helena, Montana, Verenigde Staten, 59601
        • St. Peter's Hospital
      • Kalispell, Montana, Verenigde Staten, 59901
        • Kalispell Regional Medical Center
      • Kalispell, Montana, Verenigde Staten, 59901
        • Glacier Oncology, PLLC
      • Kalispell, Montana, Verenigde Staten, 59901
        • Kalispell Medical Oncology at KRMC
      • Missoula, Montana, Verenigde Staten, 59807-7877
        • Montana Cancer Specialists at Montana Cancer Center
      • Missoula, Montana, Verenigde Staten, 59807
        • Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
    • North Carolina
      • Goldsboro, North Carolina, Verenigde Staten, 27534
        • Wayne Memorial Hospital, Incorporated
      • Hendersonville, North Carolina, Verenigde Staten, 28791
        • Pardee Memorial Hospital
    • Ohio
      • Bellefontaine, Ohio, Verenigde Staten, 43311
        • Mary Rutan Hospital
      • Chillicothe, Ohio, Verenigde Staten, 45601
        • Adena Regional Medical Center
      • Columbus, Ohio, Verenigde Staten, 43214-3998
        • Riverside Methodist Hospital Cancer Care
      • Columbus, Ohio, Verenigde Staten, 43222
        • Mount Carmel Health - West Hospital
      • Columbus, Ohio, Verenigde Staten, 43215
        • CCOP - Columbus
      • Columbus, Ohio, Verenigde Staten, 43215
        • Grant Medical Center Cancer Care
      • Columbus, Ohio, Verenigde Staten, 43228
        • Doctors Hospital at Ohio Health
      • Delaware, Ohio, Verenigde Staten, 43015
        • Grady Memorial Hospital
      • Lancaster, Ohio, Verenigde Staten, 43130
        • Fairfield Medical Center
      • Marietta, Ohio, Verenigde Staten, 45750
        • Strecker Cancer Center at Marietta Memorial Hospital
      • Mount Vernon, Ohio, Verenigde Staten, 43050
        • Knox Community Hospital
      • Newark, Ohio, Verenigde Staten, 43055
        • Licking Memorial Cancer Care Program at Licking Memorial Hospital
      • Springfield, Ohio, Verenigde Staten, 45505
        • Community Hospital of Springfield and Clark County
      • Westerville, Ohio, Verenigde Staten, 43081
        • Mount Carmel St. Ann's Cancer Center
      • Zanesville, Ohio, Verenigde Staten, 43701
        • Genesis - Good Samaritan Hospital
    • South Carolina
      • Charleston, South Carolina, Verenigde Staten, 29425
        • Hollings Cancer Center at Medical University of South Carolina
    • Utah
      • American Fork, Utah, Verenigde Staten, 84003
        • American Fork Hospital
      • Cedar City, Utah, Verenigde Staten, 84720
        • Sandra L. Maxwell Cancer Center
      • Logan, Utah, Verenigde Staten, 84321
        • Logan Regional Hospital
      • Murray, Utah, Verenigde Staten, 84157
        • Jon and Karen Huntsman Cancer Center at Intermountain Medical Center
      • Ogden, Utah, Verenigde Staten, 84403
        • Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
      • Provo, Utah, Verenigde Staten, 84604
        • Utah Valley Regional Medical Center - Provo
      • Saint George, Utah, Verenigde Staten, 84770
        • Dixie Regional Medical Center - East Campus
      • Salt Lake City, Utah, Verenigde Staten, 84143
        • LDS Hospital
      • Salt Lake City, Utah, Verenigde Staten, 84106
        • Utah Cancer Specialists at UCS Cancer Center
    • Washington
      • Bellingham, Washington, Verenigde Staten, 98225
        • St. Joseph Cancer Center
      • Bremerton, Washington, Verenigde Staten, 98310
        • Olympic Hematology and Oncology
      • Kennewick, Washington, Verenigde Staten, 99336
        • Columbia Basin Hematology
      • Mount Vernon, Washington, Verenigde Staten, 98274
        • Skagit Valley Hospital Cancer Care Center
      • Poulsbo, Washington, Verenigde Staten, 98370
        • Harrison Poulsbo Hematology and Onocology
      • Seattle, Washington, Verenigde Staten, 98109
        • Fred Hutchinson Cancer Research Center
      • Seattle, Washington, Verenigde Staten, 98104
        • Harborview Medical Center
      • Seattle, Washington, Verenigde Staten, 98104
        • Minor and James Medical, PLLC
      • Seattle, Washington, Verenigde Staten, 98112
        • Group Health Central Hospital
      • Seattle, Washington, Verenigde Staten, 98122-4307
        • Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
      • Seattle, Washington, Verenigde Staten, 98195
        • University Cancer Center at University of Washington Medical Center
      • Spokane, Washington, Verenigde Staten, 99202
        • Cancer Care Northwest - Spokane South
      • Spokane, Washington, Verenigde Staten, 99218
        • Evergreen Hematology and Oncology, PS
      • Wenatchee, Washington, Verenigde Staten, 98801-2028
        • Wenatchee Valley Medical Center
    • Wyoming
      • Sheridan, Wyoming, Verenigde Staten, 82801
        • Welch Cancer Center at Sheridan Memorial Hospital

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar tot 120 jaar (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

DISEASE CHARACTERISTICS:

  • Biopsy-proven* bronchioloalveolar carcinoma (BAC) or BAC variants (e.g., adenocarcinoma with BAC features, BAC with invasive adenocarcinoma) meeting the following criteria:

    • Incompletely resected or unresectable disease
    • No component of squamous cell carcinoma

    • Disease staged as 1 of the following:

      • Stage IIIB disease (T4 [cytologically confirmed malignant pleural effusion OR pleural tumor foci that are separate from direct pleural invasion by the primary tumor], any N, M0)

      • Stage IV disease (any T, any N, M1 [distant metastases present])

        • Recurrent disease in a separate lobe after prior resection within the past 5 years; multifocal lesions in > 1 lobe; or any disease that is recurrent after surgery or radiotherapy is considered stage IV disease
    • Tumor may be multifocal or diffuse NOTE: *Cytology specimens, including bronchial brushing, washings, or fine needle aspiration specimens, alone are not acceptable for diagnosis

  • Measurable or nonmeasurable disease by chest CT scan

    • Pleural effusions, ascites, and laboratory parameters are not acceptable as only evidence of disease
    • Disease must be present outside field of prior radiotherapy OR a new lesion must be inside port
  • Treated brain metastases allowed provided the patient is asymptomatic and do not require steroids

PATIENT CHARACTERISTICS:

  • Zubrod performance status 0-2
  • Absolute neutrophil count ≥ 1,500/mm³
  • Platelet count ≥ 100,000/mm³
  • Total bilirubin normal
  • AST or AST ≤ 2.5 times upper limit of normal (ULN) (5 times ULN if liver metastases are present)
  • Alkaline phosphatase ≤ 2.5 times ULN (5 times ULN if bone metastases are present)
  • Creatinine ≤ 1.5 times ULN OR creatinine clearance ≥ 50 mL/min
  • Urine protein:creatinine ratio ≤ 0.5 OR urine protein < 1 g by 24-hour urine collection
  • Willing to provide prior smoking history
  • No hemoptysis ≥ ½ teaspoon within the past 28 days
  • No clinical history of pulmonary or upper respiratory hemorrhage > grade 2 within the past 6 months or > grade 1 within the past 28 days
  • No history of thromboses or hemorrhage, including hemorrhagic or thrombotic stroke, or other CNS bleeding
  • No uncontrolled hypertension
  • No serious nonhealing wound, ulcer, or bone fracture

  • No other prior malignancy except for any of the following:

    • Adequately treated basal cell or squamous cell skin cancer
    • In situ cervical cancer
    • Adequately treated stage I or II cancer that is currently in complete remission
    • Any other cancer from which the patient has been disease free for 5 years
  • Not pregnant or nursing
  • Fertile patients must use effective contraception

PRIOR CONCURRENT THERAPY:

  • See Disease Characteristics
  • Recovered from prior therapy
  • At least 28 days since prior radiotherapy (14 days for palliative radiotherapy)
  • At least 28 days since prior surgery (thoracic or other major surgeries)
  • More than 7 days since prior fine-needle aspiration or core biopsy
  • At least 28 days since prior systemic chemotherapy or biologic therapy
  • No prior gefitinib hydrochloride, erlotinib hydrochloride, or bevacizumab
  • No other prior anti-epidermal growth factor receptor or anti-vascular endothelial growth factor therapies
  • Concurrent stable, therapeutic anticoagulation therapy allowed (i.e., warfarin or low molecular weight heparin), provided the patient has no history of bleeding complications on anticoagulation or an inability to establish a stable therapeutic regimen for anticoagulation
  • No other concurrent anticancer therapy, including surgery, chemotherapy, hormone therapy, biologic therapy, or radiotherapy

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: NVT
  • Interventioneel model: Opdracht voor een enkele groep
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Erlotinib and Bevacizumab
Biologisch: bevacizumab
Geneesmiddel: erlotinib hydrochloride

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Tijdsspanne
Overall Survival
Tijdsspanne: From date of registration to maximum of 3 years
From date of registration to maximum of 3 years

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Progression-free Survival
Tijdsspanne: From date of registration to maximum of 3 years
From date of registration to maximum of 3 years
Response as Assessed by RECIST Criteria vs Central Computer-assisted Image-analysis System in Patients With Measurable Disease
Tijdsspanne: From date of registration to maximum of 3 years
Images for response assessed by the central computer-assisted image-analysis system were never collected.
From date of registration to maximum of 3 years
Frequency and Severity of Toxicities
Tijdsspanne: From date of registration to maximum of 3 years
From date of registration to maximum of 3 years

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

Southwest Oncology Group

Medewerkers

National Cancer Institute (NCI)

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Algemene publicaties

  • West HJ, Moon J, Hirsch FR, et al.: SWOG S0635 and S0636: Phase II trials in advanced-stage NSCLC of erlotinib (OSI-774) and bevacizumab in bronchioloalveolar carcinoma (BAC) and adenocarcinoma with BAC features (adenoBAC), and in never-smokers with primary NSCLC adenocarcinoma (adenoCa). [Abstract] J Clin Oncol 30 (Suppl 15): A-7517, 2012.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start

1 juli 2007

Primaire voltooiing (Werkelijk)

20 juli 2019

Studie voltooiing (Werkelijk)

20 augustus 2019

Studieregistratiedata

Eerst ingediend

15 februari 2007

Eerst ingediend dat voldeed aan de QC-criteria

15 februari 2007

Eerst geplaatst (Schatting)

19 februari 2007

Updates van studierecords

Laatste update geplaatst (Werkelijk)

2 april 2020

Laatste update ingediend die voldeed aan QC-criteria

20 maart 2020

Laatst geverifieerd

1 maart 2020

Meer informatie

Termen gerelateerd aan deze studie

Trefwoorden

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • CDR0000529756
  • U10CA032102 (Subsidie/contract van de Amerikaanse NIH)
  • S0635 (Andere identificatie: SWOG)

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren